Did Medicare Part D Reduce Disparities?
This study examined the impact of the Medicare Part D coverage gap on medication use by Hispanics, blacks, and whites with diabetes.
Coverage and Use of Cancer Therapies in the Treatment of Chronic Myeloid Leukemia
Physician Prescribing Behavior and Its Impact on Patient-Level Outcomes
Physicians prescribe more broadly than commonly perceived. Although most physicians have a favorite drug, they are not reluctant to try new therapies.
Medicare Part D After 2 Years
Coverage under Part D is comparable to that under non–Part D plans with respect to key features likely to be important to Medicare beneficiaries.
Impact of Specialty Drugs on the Use of Other Medical Services
Biologic therapy for rheumatoid arthritis or multiple sclerosis was associated with lower use of some types of medical services within 2 to 3 years of initiation.
Varying Pharmacy Benefits With Clinical Status: The Case of Cholesterol-lowering Therapy
Moving Towards Better Formulary Management
Visits to Primary Care Physicians and to Specialists Under Gatekeeper and Point-of-Service Arrangements
